Coronavirus (COVID-19) updates for UC San Diego Health patients and visitors. Learn More

Menu
Search

UCSD's Ajit Varki To Receive Glycobiology's Highest International Honor

 

March 07, 2007  |  

Ajit Varki, M.D., Distinguished Professor of Medicine and Cellular and Molecular Medicine, and Founder and Co-Director of the Glycobiology Research and Training Center at the

Ajit Varki, M.D.

University of California, San Diego (UCSD) School of Medicine, has been selected as the winner of the International Glycoconjugate Organization (IGO) Award for 2007.  The award which is given every two years to "glycoscientists who have clearly advanced the field of glycoscience and show promise of continuing advancements," will be presented at the 19th International Symposium on Glycoconjugates (GLYCO XIX) scheduled in Cairns, Queensland, Australia, July 15 to 20. 

Varki has been a pioneer in the field of glycobiology, which is the study of the structure, biosynthesis and biology of complex sugar chains called glycans which cover all cells and many proteins in nature.  Varki‚Äôs research interests focus on a family of sugars called the sialic acids, and their roles in biology, evolution and disease.  He has identified and studied multiple differences in sialic acid biology between humans and great apes, differences that are relevant to understanding aspects of human health and disease.  Varki is the chief editor of the major textbook in the field, The Essentials of Glycobiology.

This award is the highest international honor in the field of Glycobiology. Varki is one of only three Americans to have won it. He is already 2005 winner of the Karl Meyer Award of the Society for Glycobiology, the other major honor in this field.  Varki is one of three individuals to date who have won both awards.

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu

 




Media Contact

Share This Article


Related News

8/5/2020
Researchers at UC San Diego School of Medicine report successfully implanting specialized grafts of neural stem cells directly into spinal cord injuries in mice, then documenting how the grafts grew a ...
8/5/2020
The National Institutes of Health will soon launch a Phase II clinical trial to evaluate the safety and efficacy of potential new therapeutics for COVID-19, including the use of investigational synthe ...
8/4/2020
Researchers at University of California San Diego School of Medicine report that sleep may help people to learn continuously through their lifetime by encoding new memories and protecting old ones.
8/3/2020
UC San Diego researchers discovered that people with an inactive RNA-editing enzyme respond better to cancer immunotherapy, and inhibitors of the enzyme help mice with difficult-to-treat cancers live ...



Follow Us